USD 4.46
(-4.9%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 22.58 Million USD | -4.31% |
2022 | 23.3 Million USD | -33.43% |
2021 | 35 Million USD | -2.44% |
2020 | 35.87 Million USD | 56.64% |
2019 | 22.9 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 10.24 Million USD | 56.78% |
2024 Q1 | 6.53 Million USD | -33.72% |
2023 Q3 | 3.32 Million USD | -36.38% |
2023 FY | 22.29 Million USD | -4.31% |
2023 Q4 | 9.86 Million USD | 196.34% |
2023 Q2 | 5.23 Million USD | 27.63% |
2023 Q1 | 4.1 Million USD | 20.59% |
2022 Q4 | 3.4 Million USD | -26.3% |
2022 Q3 | 4.61 Million USD | -30.11% |
2022 Q1 | 8.75 Million USD | 245.93% |
2022 FY | 23.3 Million USD | -33.43% |
2022 Q2 | 6.6 Million USD | -24.62% |
2021 Q1 | 12.68 Million USD | 24.73% |
2021 Q4 | -6 Million USD | -140.32% |
2021 Q3 | 14.88 Million USD | 10.08% |
2021 FY | 35 Million USD | -2.44% |
2021 Q2 | 13.51 Million USD | 6.58% |
2020 Q1 | 7.04 Million USD | 0.0% |
2020 Q4 | 10.16 Million USD | 3.49% |
2020 Q3 | 9.82 Million USD | 11.09% |
2020 Q2 | 8.84 Million USD | 25.63% |
2020 FY | 35.87 Million USD | 56.64% |
2019 FY | 22.9 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Abbott Laboratories | 22.13 Billion USD | 99.898% |
Allurion Technologies Inc. | 41.49 Million USD | 45.57% |
Artivion, Inc. | 229.17 Million USD | 90.144% |
Avanos Medical, Inc. | 379.7 Million USD | 94.051% |
Butterfly Network, Inc. | 16.85 Million USD | -34.0% |
Butterfly Network, Inc. | 16.85 Million USD | -34.0% |
Bio-Rad Laboratories, Inc. | 1.43 Billion USD | 98.422% |
Boston Scientific Corporation | 9.89 Billion USD | 99.772% |
Perspective Therapeutics, Inc. | 1.63 Million USD | -1282.313% |
CONMED Corporation | 643.06 Million USD | 96.488% |
Edwards Lifesciences Corporation | 4.62 Billion USD | 99.512% |
Paragon 28, Inc. | 172.79 Million USD | 86.928% |
Glaukos Corporation | 239.13 Million USD | 90.555% |
Globus Medical, Inc. | 1.02 Billion USD | 97.786% |
Inspire Medical Systems, Inc. | 528.22 Million USD | 95.724% |
Integer Holdings Corporation | 418.28 Million USD | 94.6% |
Medtronic plc | 19.45 Billion USD | 99.884% |
Nevro Corp. | 290.06 Million USD | 92.213% |
Penumbra, Inc. | 682.64 Million USD | 96.691% |
Vicarious Surgical Inc. | -1.85 Million USD | 1318.285% |
Smith & Nephew plc | 3.7 Billion USD | 99.39% |
Sonendo, Inc. | 10.72 Million USD | -110.66% |
STERIS plc | 2.23 Billion USD | 98.989% |
Stryker Corporation | 13.05 Billion USD | 99.827% |
Vapotherm, Inc. | 28.28 Million USD | 20.139% |
Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | 99.575% |